Molnupiravir to 1,000 patients

Almost a thousand patients in Cyprus have been administered Molnupiravir, the antiviral medication for COVID, said Deputy head of pharmaceutical services Elena Panagiotopoulou. Merck anti-Covid oral pill Molnupiravir /Lagevrio 200mg has been administered to 984 patients, and 7% of them had to be admitted to the hospital. She told CNA no deaths or any side-effects were reported.

Panagiotopoulou said that authorities could not draw safe conclusions regarding the drug’s efficacy. This is only possible if, at the same time this medication was given, a placebo drug was given to an equal number of patients.

She explained that it is a bit risky to draw any conclusions, but it is better to have the drug than not have it at all.